Laccona Nicholas 4
4 · Bellerophon Therapeutics, Inc. · Filed Feb 14, 2023
Insider Transaction Report
Form 4
Laccona Nicholas
Controller, (PFO & PAO)
Transactions
- Award
Stock Options (right to buy)
2023-02-10$1.52/sh+50,000$76,000→ 50,000 totalExercise: $1.52Exp: 2033-02-10→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This option vests as to 25% of the underlying shares on February 10, 2024 and the remaining options vest quarterly over a period of 3 years thereafter.